YS Lim

机构：Dongguk University, Dongguk University Ilsan Hospital

发表论文 15 篇 · 总被引 152 次 · h-index 4

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 117)
• Safety and pharmacodynamics of the GALNAC-siRNA AB-729 in subjects with chronic hepatitis B infection (2020 · 被引 14)
• Thermoelectric Properties of Ca<SUB>1−<I>x</I>−<I>y</I></SUB>Dy<SUB><I>x</I></SUB>Ce<SUB><I>y</I></SUB>MnO<SUB>3</SUB> for Power Generation (2011 · Journal of Nanoscience and Nanotechnology · 被引 7)
• Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B (2018 · 被引 4)
• Influence of Sintering Temperature on the Microstructure and Thermoelectric Properties of Polycrystalline Fe<SUB>1.9925</SUB>P<SUB>0.0075</SUB>O<SUB>3</SUB> (2013 · Journal of Nanoscience and Nanotechnology · 被引 4)
• Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection: The Impact of Treatment and Sustained Virologic Response (SVR) (2017 · 被引 2)